Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/87621
Citations
Scopus Web of Science® Altmetric
?
?
Type: Conference item
Title: The tyrosine kinase inhibitor dasatinib decreases osteoclast formation and activity in vitro
Author: Vandyke, K.
Dewar, A.L.
Davis, A.N.
Fiuer, S.
Hughes, T.P.
To, L.B.
Zannettino, A.C.W.
Citation: 30th Annual Meeting of the American Society for Bone and Mineral Research, as published in Journal of Bone and Mineral Research, 2008 / vol.23, iss.Suppl. s1, pp.S260-S261
Publisher: Wiley
Issue Date: 2008
ISSN: 0884-0431
Conference Name: 30th Annual Meeting of the American Society for Bone and Mineral Research (12 Sep 2008 - 16 Sep 2008 : Montreal, Canada)
Statement of
Responsibility: 
K. Vandyke, A. L. Dewar, A. N. Davis, S. Fitter, T. P. Hughes, L. B. To, A. C. W. Zannettino
Description: Conference abstract SU074
Rights: Copyright © 2008 ASBMR
RMID: 0030014316
DOI: 10.1002/jbmr.5650231305
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.